Safety and Pharmacokinetics of RTH258 in Subjects With Age-Related Macular Degeneration
Condition(s):Neovascular Age-Related Macular DegenerationLast Updated:July 2, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Neovascular Age-Related Macular DegenerationLast Updated:July 2, 2018Completed
Condition(s):Macular DegenerationLast Updated:August 3, 2020Completed
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:October 26, 2022Completed
Condition(s):Neovascular Age-related Macular Degeneration; Age-Related Macular Degeneration; Wet Macular DegenerationLast Updated:March 28, 2024Recruiting
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:December 14, 2023Active, not recruiting
Condition(s):Neurovascular Age-related Macular DegenerationLast Updated:April 28, 2023Completed
Condition(s):Neovascular Age-related Macular Degeneration (nAMD); Diabetic Macular Edema (DME)Last Updated:March 28, 2024Active, not recruiting
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:September 14, 2022Active, not recruiting
Condition(s):Wet Age-related Macular DegenerationLast Updated:February 23, 2024Completed
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:December 19, 2020Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.